July 3, 2025Open Access

The spectrum of overlapping anti-NMDAR encephalitis and demyelinating syndromes: a systematic review of presentation, diagnosis, management, and outcomes

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Anti-NMDAR encephalitis overlapping with demyelinating diseases is challenging. Tailored treatments based on detailed immune profiles are key to better outcomes.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Saeed et al. (Thu,) studied this question.

synapsesocial.com/papers/69d6c30e39aaaf0da5ab3509 https://doi.org/https://doi.org/10.1080/07853890.2025.2517813

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical Characteristics of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review2022 · 15 citations
2Myelin oligodendrocyte glycoprotein antibody and <i>N</i>-methyl-<scp>d</scp>-aspartate receptor antibody overlapping syndrome: insights from the recent case reports2023 · 16 citations
3Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica2020 · 89 citations
4Clinical characteristics of Chinese pediatric patients positive for anti-NMDAR and MOG antibodies: a case series2024 · 8 citations
5Clinical features of adult patients with positive NMDAR-IgG coexisting with MOG-IgG2024 · 4 citations

Me gusta

Guardar

Ver artículo completo